| Naslov: | Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variability |
|---|
| Avtorji: | ID Steinestel, Konrad (Avtor)
ID Löwer-Kiem, Lena-Maria (Avtor)
ID Ambrosi, Francesca (Avtor)
ID Becker, Anne-Sophie (Avtor)
ID Bohnenberger, Hanibal (Avtor)
ID Bräutigam, Konstantin (Avtor)
ID Cazzato, Gerardo (Avtor)
ID Conde, Esther (Avtor)
ID Cozac-Szőke, Andreea-Raluca (Avtor)
ID Curto, Daniel (Avtor)
ID Dahlberg, Jan-Olof (Avtor)
ID Gama, João Martins (Avtor)
ID Gambella, Alessandro (Avtor)
ID Hutarew, Georg (Avtor)
ID Lopez-Rios, Fernando (Avtor)
ID Lucà, Stefano (Avtor)
ID Lunardi, Francesca (Avtor)
ID Matek, Christian (Avtor)
ID Meyer, Christian (Avtor)
ID Olteanu, Gheorghe-Emilian (Avtor)
ID Popper, Helmut H. (Avtor)
ID Roden, Anja C (Avtor)
ID Samaras, Menelaos G (Avtor)
ID Skok, Kristijan (Avtor)
ID Suster, David (Avtor)
ID Weissferdt, Annikka (Avtor)
ID Zustin, Jozef (Avtor)
ID Kümpers, Christiane (Avtor)
ID Elsner, Felix (Avtor) |
|---|
| Datoteke: |  RAZ_Steinestel_Konrad_2026.pdf (2,20 MB)
MD5: 3A1E7F3368F695B3A2BCC5AEEC798C93
 https://doi.org/10.1016/j.lungcan.2026.109510
https://linkinghub.elsevier.com/retrieve/pii/S0169500226005714
|
|---|
| Jezik: | Angleški jezik |
|---|
| Vrsta gradiva: | Znanstveno delo |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: | MF - Medicinska fakulteta
|
|---|
| Opis: | Background PD-L1 tumor proportion score (TPS) is used to guide immunotherapy in non-small cell lung cancer (NSCLC), yet its ability to predict pathological response in the neoadjuvant setting remains limited. Methods Thirty pathologists from 11 countries independently assessed PD-L1 TPS in pre-treatment biopsies and residual viable tumor (RVT) in matched resection specimens after neoadjuvant chemoimmunotherapy in 30 digitized cases from the ReGraDE (regression grading in Germany) study. Interobserver agreement was evaluated using intraclass correlation coefficients (ICC) and Fleiss’ kappa. Associations between TPS and RVT were analyzed using Pearson correlation, and correlations derived from single-rater and averaged TPS were compared using the Williams test. Results Interobserver agreement was moderate for both TPS and RVT (ICC = 0.74, 95% CI 0.60–0.87, and ICC = 0.74, 95% CI 0.62–0.85, respectively) and became near-perfect when mean scores per case were calculated across observers (ICC = 0.99, for both). However, TPS remained poorly correlated with RVT for both single-rater assessment (r = –0.17, p = 0.38) and averaged TPS (r = –0.16, p = 0.39) with no significant difference between these approaches (p = 0.96). Differences in interpretation thresholds were observed particularly in borderline cases around the 1% TPS cut-off and in distinguishing 0% from minimal RVT, but did not account for the lack of association between TPS and RVT. Systematic differences were observed depending on individual professional experience, particularly in borderline cases. Conclusion Interobserver variability does not explain the limited predictive value of PD-L1 TPS in the neoadjuvant setting, suggesting an intrinsic limitation of the biomarker. |
|---|
| Ključne besede: | non-small cell lung cancer (NSCLC), PD-L1, tumor proportion score (TPS), residual viable tumor (RVT), neoadjuvant chemoimmunotherapy, interobserver variability |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Poslano v recenzijo: | 05.06.2026 |
|---|
| Datum sprejetja članka: | 05.05.2026 |
|---|
| Datum objave: | 01.08.2026 |
|---|
| Založnik: | Elsevier |
|---|
| Leto izida: | 2026 |
|---|
| Št. strani: | str. [1]-8 |
|---|
| Številčenje: | Letn. 218, Aug. 2026, št. članka 109510 |
|---|
| PID: | 20.500.12556/DKUM-100352  |
|---|
| UDK: | 616-006 |
|---|
| COBISS.SI-ID: | 291043075 |
|---|
| DOI: | 10.1016/j.lungcan.2026.109510 |
|---|
| ISSN pri članku: | 1872-8332 |
|---|
| Datum objave v DKUM: | 15.09.2026 |
|---|
| Število ogledov: | 102 |
|---|
| Število prenosov: | 0 |
|---|
| Metapodatki: |    |
|---|
| Področja: | Ostalo
|
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Skupna ocena: | (0 glasov) |
|---|
| Vaša ocena: | Ocenjevanje je dovoljeno samo prijavljenim uporabnikom. |
|---|
| Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
